Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Complex Trial Design Pilot May Change 'Ambitious' Timelines

16 Apr 2019

• By Derrick Gingery

Drug costs_1A_546120055_1200.jpg

Related Content

US FDA Offers Sponsors More Attention For Sharing Complex Innovative Trial Designs

04 Apr 2018

Complex Innovative Designs Pilot Likely Satisfies Industry's Disclosure Worries

29 Aug 2018

US FDA's Complex Trial Design Pilot Might Be Handicapped By Disclosure Requirements

17 May 2018

Norman Sharpless Will Arrive At US FDA With Many Challenges Awaiting

28 Mar 2019

Finance Watch: Gossamer Works Around The Shutdown To Price Its $230m IPO

26 Jan 2019

Related Companies

Wave Life Sciences Ltd.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Clinical Trials Regulation FDA BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.